β³ Fetching live dividend data...
Home βΊ Calculator βΊ NSTG Dividend Calculator 2026
NanoString Technologies, Inc. Β· NASDAQ
Price: $0.11 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NSTG β $640534.68M in 10 years Β· $45,162,300,675.64/month
NanoString Technologies, Inc. is a global innovator in scientific instrumentation, designing and producing advanced research tools for genomics and proteomics across the Americas, Europe, the Middle East, and Asia Pacific. Its flagship offering is the nCounter Analysis System, an automated platform renowned for its versatile digital detection and counting capabilities. This system includes both nCounter MAX and FLEX configurations, which integrate a Prep Station for automated liquid handling and sample preparation, alongside a Digital Analyzer. The Analyzer captures data by imaging fluorescent reporters within sample cartridges, then processes this information into usable output files. The company also offers the nCounter SPRINT Profiler, a compact instrument that streamlines liquid handling and digital analysis using a specialized microfluidic cartridge. Complementing its hardware, NanoString provides nSolver Analysis Software, a powerful program enabling researchers to verify, normalize, and interpret their experimental data. Further extending its product portfolio, NanoString supplies customizable CodeSets and pre-designed panels tailored for applications in oncology, immunology, infectious diseases, and neuroscience. Essential Master Kits, containing reagents and plasticware, are also available to facilitate sample setup and processing within their nCounter Prep Station and Digital Analyzer. Additionally, they market Prosigna molecular diagnostic test kits. Looking ahead, NanoString is actively developing the GeoMx DSP system, poised to advance the field of spatial genomics. The company maintains strategic partnerships, including collaborations with Lam Research Corporation for the research and development of Hyb & Seq technologies, and with Celgene Corporation on LymphMark, an in vitro diagnostic for diffuse large B-cell lymphoma. They also work with the Parker Institute for Cancer Immunotherapy to improve CAR-T regimens and patient outcomes across various cancer types. Established in 2003, NanoString Technologies, Inc. operates from its headquarters in Seattle, Washington.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open NSTG position with:
Real after-tax yield depends on where you live and how you hold NSTG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 1899.34% | 1896.54% | $189,934 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1614.44% | 1611.64% | $161,444 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1519.47% | 1516.67% | $151,947 / yr |
| π¬π§ UK ISA | 0% | 1899.34% | 1896.54% | $189,934 / yr |
| π¬π§ UK Taxable | 8.75% | 1733.15% | 1730.35% | $173,315 / yr |
| π¨π¦ TFSA | 0% | 1899.34% | 1896.54% | $189,934 / yr |
| π¨π¦ CA Taxable | 25% | 1424.50% | 1421.70% | $142,451 / yr |
| π¦πΊ Super (pension) | 15% | 1614.44% | 1611.64% | $161,444 / yr |
| π¦πΊ AU Taxable | 30% | 1329.54% | 1326.74% | $132,954 / yr |
| π©πͺ DE Taxable | 26.375% | 1398.39% | 1395.59% | $139,839 / yr |
| π«π· FR Taxable | 30% | 1329.54% | 1326.74% | $132,954 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
NSTG pays quarterly β 4 times per year. Next ex-div: TBD.
How NSTG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NSTG sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2024-05-06 | 34,848 | β | β | ||
| M-Exempt | 2024-05-06 | 104,545 | β | β | ||
| M-Exempt | 2024-05-06 | 8,460 | β | β | ||
| M-Exempt | 2024-05-06 | 104,545 | β | β | ||
| M-Exempt | 2024-05-06 | 69,697 | β | β | ||
| M-Exempt | 2024-05-06 | 69,697 | β | β | ||
| M-Exempt | 2024-05-06 | 104,545 | β | β | ||
| M-Exempt | 2024-05-06 | 8,460 | β | β | ||
| M-Exempt | 2024-05-06 | 104,545 | β | β | ||
| M-Exempt | 2024-05-06 | 69,697 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NSTG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
NanoString Technologies, Inc. (NSTG) is currently trading at $0.11, 100% below its 52-week high. The current dividend yield is 1899.34% based on an annual payout of $2.00 per share.
NanoString Technologies, Inc. (NSTG) is a healthcare stock currently trading at $0.11 with a dividend yield of 1899.34%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, NSTG has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only β not financial advice.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever